Regeneron Gene Therapy Wins FDA Fast Track, White House Drug Deal Looms
June 25, 2026·20 days ago·via Stocktwits

Regeneron's breakthrough gene therapy for genetic hearing loss just got the FDA's accelerated approval stamp - a win for innovation and patients desperate for real solutions. The White House is announcing a drug pricing deal today, signaling the administration's willingness to work with pharma on affordability without crushing the incentives that drive medical breakthroughs. Read more about this...